// App-Quantinova.ai

O029 : Clinical outcomes of the first 2 years of implementation of the integrated care pathway for concurrent major depressive disorder and alcohol use disorder

Researchers

Presenter

  • A.V.Samokhvalov

Principal Investigators

  • S.Awan

  • B.Le Foll

  • C.Probst

  • P.Voore

  • J.Rehm

Medical Centers

  • Centre for Addiction and Mental Health, Institute for Mental Health Policy Research/Addiction Medicine Service, Toronto, Canada

  • Centre for Addiction and Mental Health, Integrated Care Pathways Program, Toronto, Canada

  • Centre for Addiction and Mental Health, Addiction Medicine Service, Toronto, Canada

  • Centre for Addiction and Mental Health, Institute for Mental Health Policy Research/Addiction Medicine Service, Toronto, Canada

  • Centre for Addiction and Mental Health, Ambulatory Care and Structured Treatments, Toronto, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • Tau protein

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A